Medical Update on Nerivio: Heads UP–Episode 75

[fusion_builder_container hundred_percent="yes" overflow="visible" type="legacy" admin_label="post"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_color="" border_style="solid" spacing="yes" background_image="" background_repeat="no-repeat" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="no" center_content="no" min_height="none" align_self="flex-start" border_sizes_undefined="" first="true" last="true" hover_type="none" link="" border_position="all"][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" content_alignment_medium="" content_alignment_small="" content_alignment="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" sticky_display="normal,sticky" class="" id="" font_size="" fusion_font_family_text_font="" fusion_font_variant_text_font="" line_height="" letter_spacing="" text_color="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset=""][fusion_dropcap color="" boxed="yes" boxed_radius="50%" class="" id=""]D[/fusion_dropcap]r. Lindsay Weitzel welcomes back Dr. Timothy Smith to Heads UP to discuss the real-world data recently released on Nerivio as a treatment for migraine disease. Nerivio is a wireless remote electrical neuromodulation device for the acute treatment of migraine with or without aura in patients 18 years of age or older who do not have chronic migraine.[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

Previous
Previous

Migraine Stigma, Disability, and Workplace Discrimination: Heads UP–Episode 76

Next
Next

Migraine at Work: Heads UP–Episode 74